Gene transfer system derived from the caprine arthritis-encephalitis lentivirus

Journal of Virological Methods

Volumn 136, Issue 1-2, 2006, Pages 177-184

  Mselli Lakhal, Laila ^a   Guiguen, François ^a   Greenland, Timothy ^a   Mornex, Jean François ^a   Chebloune, Yahia ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

CAEV; Gene; Lentivirus; Tool; Transfer; Vector

Indexed keywords

GAG PROTEIN; LENTIVIRUS VECTOR; POL PROTEIN;

ANIMAL CELL; ARTICLE; CAPRINE ARTHRITIS ENCEPHALITIS LENTIVIRUS; CELL DIVISION; CELL LINE; CONTROLLED STUDY; ENVELOPE GENE; GENE CASSETTE; GENE TRANSFER; GENOME; HOST; HUMAN; HUMAN CELL; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA TRANSPORT; SPECIES IDENTIFICATION; STRUCTURAL GENE; VIRUS GENE;

ARTHRITIS-ENCEPHALITIS VIRUS, CAPRINE; BIOLOGICAL TRANSPORT; CELL LINE; CYTOMEGALOVIRUS; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, ENV; GENES, GAG; GENES, POL; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELPER VIRUSES; HUMANS; MEMBRANE GLYCOPROTEINS; PROMOTER REGIONS (GENETICS); RNA, VIRAL; VIRAL ENVELOPE PROTEINS; VIRUS ASSEMBLY;

CAPRA; CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 33745918305     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.05.006     Document Type: Article

References (44)

1. Adams D.S., Klevjer-Anderson P., Carlson B.S., and McGuire T.C. Transmission and control of caprine arthritis-encephalitis virus. Am. J. Vet. Res. 44 (1983) 1670-1675
2. Amado R.G., and Chen I.S. Lentiviral vectors the promise of gene therapy within reach?. Science 285 (1999) 674-676
3. Anson D.S., and Fuller M. Rational development of a HIV-1 gene therapy vector. J. Gene. Med. 5 (2003) 829-838
4. Berkowitz R.D., Ilves H., Plavec I., and Veres G. Gene transfer systems derived from visna virus: analysis of virus production and infectivity. Virology 279 (2001) 116-129
5. Blömer U., Naldini L., Kafri T., Trono D., Verma I.M., and Gage F.H. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71 (1997) 6641-6649
6. Buchschacher Jr. G.L., and Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood 95 (2000) 2499-2504
7. Bukrinsky M.I., Haggerty S., Dempsey M.P., Sharova N., Adzhubel A., Spitz L., Lewis P., Goldfarb D., Emerman M., and Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365 (1993) 666-669
8. Burns J.C., Friedmann T., Driever W., Burrascano M., and Yee J.K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and non-mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8033-8037
9. Chebloune Y., Sheffer D., Karr B.M., Stephens E., and Narayan O. Restrictive type of replication of ovine/caprine lentiviruses in ovine fibroblast cell cultures. Virology 222 (1996) 221-230
10. Crawford T.B., and Adams D.S. Caprine arthritis-encephalitis: clinical features and presence of antibody in selected populations. J. Am. Vet. Med. Assoc. 178 (1981) 713-719
11. Da Silva Teixeira M.F., Lambert V., Mselli-Lakahl L., Chettab A., Chebloune Y., and Mornex J.F. Immortalization of caprine fibroblasts permissive for replication of small ruminant lentiviruses. Am. J. Vet. Res. 58 (1997) 6579-6584
12. De Rijck J., Van Maele B., and Debyser Z. Position effect of the central DNA flap in HIV-1 derived lentiviral vectors. Biochem. Biophys. Res. Commun. 338 (2005) 987-994
13. Gasmi M., Glynn J., Jin M.J., Jolly D.J., Yee J.K., and Chen S.T. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors. J. Virol. 73 (1999) 1828-1834
14. Guiguen F., Mselli-Lakhal L., Fornazero C., Du J., Favier C., Durand M., Grezel D., and Chebloune Y. Experimental infection of mouflon-domestic sheep hybrids with caprine arthritis encephalitis. Am. J. Vet. Res. 4 (2000) 456-461
15. Harmache A., Vitu C., Russo P., Bouyac M., Hieblot C., Peveri P., Vigne R., and Suzan M. The caprine arthritis encephalitis virus tat gene is dispensable for efficient viral replication in vitro and in vivo. J. Virol. 69 (1995) 5445-5454
16. Harmache A., Vitu C., Russo P., Bouyac M., Hieblot C., Peveri P., Vigne R., and Suzan M. Priming with tat-deleted caprine arthritis encephalitis virus (CAEV) proviral DNA or live virus protects goats from challenge with pathogenic CAEV. J. Virol. 72 (1998) 6796-6804
17. Kafri T., Blömer U., Peterson D.A., Gage F.H., and Verma I.M. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17 (1997) 314-317
18. Kim V.N., Mitrophanous K., Kingsman S.M., and Kingsman A.J. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72 (1998) 811-816
19. Mangeot P.E., Duperrier K., Nègre D., Boson B., Rigal D., Cosset F.L., and Darlix J.L. High level of transduction of human dendritic cells with optimized SIV vectors. Mol. Ther. 5 (2002) 283-290
20. Miyoshi H., Blomer U., Takahashi M., Gage F.H., and Verma I.M. Development of self-inactivating lentivirus vectors. J. Virol. 72 (1998) 8150-8157
21. Morin T., Guiguen F., Bouzar B.A., Villet S., Greenland T., Grezel D., Gounel F., Gallay K., Garnier C., Durand J., Alogninouwa T., Mselli-Lakhal L., Mornex J.F., and Chebloune Y. Clearance of a productive lentivirus infection in calves experimentally inoculated with caprine arthritis-encephalitis virus. J. Virol. 77 (2003) 6430-6437
22. Mselli-Lakhal L., Favier C., Da Silva Teixeira F., Chettab A., Mornex J.F., and Chebloune Y. Defect in RNA transport and packaging are responsible for low transduction efficiency of CAEV-based vectors. Arch. Virol. 143 (1998) 681-695
23. Mselli-Lakhal L., Favier C., Leung K., Guiguen F., Grezel D., Mornex J.F., Narayan O., Quérat G., and Chebloune Y. Lack of functional receptors is the only barrier that prevents human cells from CAEV infection. J. Virol. 74 (2000) 8343-8348
24. Naldini L., Blömer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
25. Naldini L., Blömer U., Gage F.H., Trono D., and Verma I.M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11382-11388
26. Nash K.L., and Lever A.M. Green fluorescent protein: green cells do not always indicate gene expression. Gene Ther. 11 (2004) 882-883
27. Nègre D., and Cosset F.L. Vectors derived from simian immunodeficiency virus (SIV). Biochimie 84 (2002) 1161-1171
28. Olsen J.C. Gene transfer vectors derived from equine infectious anemia virus. Gene. Ther. 5 (1998) 1481-1487
29. O'Rourke J.P., Newbound G.C., Kohn D.B., Olsen J.C., and Bunnell B.A. Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors. J. Virol. 76 (2002) 1510-1515
30. Pandya S., Klimatcheva E., and Planelles V. Lentivirus and foamy virus vectors: novel gene therapy tools. Expert Opin. Biol. Ther. 1 (2001) 17-40
31. Pang S., Kang M.K., Kung S., Yu D., Lee A., Poon B., Chen I.S., Lindemann B., and Park N.H. Anticancer effect of a lentiviral vector capable of expressing HIV-1 Vpr. Clin. Cancer Res. 7 (2001) 3567-3573
32. Parolin C., Dorfman T., Palu G., Gottlinger H., and Sodroski J. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J. Virol. 68 (1994) 3888-3895
33. Park F., Ohashi K., Chiu W., Naldini L., and Kay M.A. Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24 (2000) 49-52
34. Poeschla E.F., Wong-Staal D.J., and Looney L. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4 (1998) 354-357
35. Richardson J.H., Child L.A., and Lever A.M. Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5′ leader region. J. Virol. 67 (1993) 3905-3997
36. Saltarelli M.J., Querat G., Konings D.A., Vigne R., and Clements J.E. Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology 179 (1990) 347-364
37. Solly S.K., Trajcevski S., Frisen C., Holzer G.W., Nelson E., Clerc B., Abordo-Adesida E., Castro M., Lowenstein P., and Klatzmann D. Replicative retroviral vectors for cancer gene therapy. Cancer Gene. Ther. 10 (2003) 30-39
38. Sutton R.E., Reitsma M.J., Uchida N., and Brown P.O. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J. Virol. 73 (1999) 3649-3660
39. Sutton R.E., Wu H.T., Rigg R., Bohnlein E., and Brown P.O. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72 (1998) 5781-5788
40. Turelli P., Petursson G., Guiguen F., Mornex J.F., Vigne R., and Querat G. Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J. Virol. 70 (1996) 1213-1217
41. Vigna E., and Naldini L. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J. Gene. Med. 2 (2000) 308-316
42. Wang G., Slepushkin V., Zabner J., Keshavjee S., Johnston J.C., Sauter S.L., Jolly D.J., Dubensky T.W., Davidson B.L., and McCray P.B. Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J. Clin. Invest. 104 (1999) R55-R62
43. Zuffery R., Donello J.E., Trono D., and Hope T.J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73 (1999) 2886-2892
44. Zufferey R., Dull T., Mandel R.J., Bukovsky A., Naldini L., and Trono D. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72 (1998) 9873-9880